VCM
TARS icon

Voleon Capital Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Voleon Capital Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.84M Sell
68,935
-8,440
-11% -$590K 0.1% 205
2025
Q4 		$6.34M Buy
77,375
+54,392
+237% +$4.06M 0.14% 171
2025
Q3 		$1.37M Buy
+22,983
New +$1.13M 0.03% 367
2025
Q1 		– Sell
-5,266
Closed -$292K – 409
2024
Q4 		$292K Buy
+5,266
New +$239K 0.02% 289

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Voleon Capital Management's TARS Position: Q1 2026 in Review

Voleon Capital Management reduced its Tarsus Pharmaceuticals (TARS) stake by 11% in Q1 2026, selling an estimated $590K and leaving 68,935 shares worth $4.84M. The position accounts for 0.1% of the portfolio, ranked #205.

Voleon Capital Management first reported a position in TARS in Q4 2024 and has held it in 4 quarters since. The position peaked at $6.34M in Q4 2025. 253 funds tracked by Wall St. Rank hold TARS as of Q1 2026.

  • Voleon Capital Management held 68,935 shares of Tarsus Pharmaceuticals worth $4.84M as of Q1 2026.
  • Voleon Capital Management sold 8,440 Tarsus Pharmaceuticals shares in Q1 2026, an estimated $590K.
  • Tarsus Pharmaceuticals made up 0.1% of Voleon Capital Management's portfolio in Q1 2026, its #205 holding.
  • Voleon Capital Management first reported a position in Tarsus Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Voleon Capital Management's Tarsus Pharmaceuticals position peaked at $6.34M in Q4 2025.
  • 253 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.